Intrommune Therapeutics
PrivateLast Round
Series A
Jun 9, 2021
Est. Valuation
$15.11M
Total Funding Raised
$5.51M
Company Overview
Intrommune Therapeutics is a biotechnology company that is developing a treatment platform for food allergies using oral mucosal immunotherapy (OMIT) delivered through a specially formulated toothpaste.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Intrommune Therapeutics Comparables
Compare Intrommune Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Moonlight Therapeutics | 81% | |
| Prota Therapeutics | 78% | |
| InnoUp Farma | 78% | |
Intrommune Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 9, 2021 | ||||
| Crowdfunding | Apr 12, 2018 |
Intrommune Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chemical Angel Network | Series A |
| Robin Hood Ventures | Series A |
| Red Bear Ventures | Series A |
| Timberline Holdings | Series A |
| Netcapital | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors increased 46% MoM.
- Nov 6, 2025
Monthly visitors increased 34% MoM.
Intrommune Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Intrommune Therapeutics's valuation, stock price, and market status.